AGS-003

IPO Preview: Argos Therapeutics
Seeking Alpha
Fri, 02/7/14 - 09:30 am
IPOs
Argos Therapeutics
AGS-003
renal cell carcinoma
Argos swings for a $60M IPO in the shadow of Dendreon's struggles
Fierce Biotech
Tue, 12/31/13 - 11:42 am
Argos
IPOs
Dendreon
AGS-003
personalized medicine
renal cell carcinoma